semaglutide vs bariatric surgery BARI-STEP: another evidence-based tool for post-MBS. ✓ . For those of us managing patients before and after metabolic (MBS), this is exciting. Post-MBS care is not always 'continue usual treatment' Metabolic Bariatric Surgery vs. GLP-1

Our programs may include options such as branded Ozempic, Wegovy, Mounjaro, or Zepbound, as well as compounded semaglutide and tirzepatide, or oral formulations of these medications, depending on your individual needs and eligibility

Wegovy and Zepbound can run upwards of $1,000 per month

If approved, we believe pemvidutide could offer an important option for obesity patients, including those with risk factors for cardiovascular disease. However, tolerability issues remain, as the trial led to one participant experiencing vomiting, and 4.1% of the patients in the drug cohort discontinuing treatment in the first 16 weeks, when compared to 2.1% in the placebo group

I started out on Wegovy and as they titrated me up to 25 mg, my monthly fee went up to $349